Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1623 1626 1627 1629 1636
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18462918 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Final Rejection | AbbVie Inc. |
| 18555025 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Non-Final OA | LG CHEM, LTD. |
| 18020493 | SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 18288314 | SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS | Non-Final OA | Eli Lilly and Company |
| 18033662 | PDE9 INHIBITORS FOR TREATING CARDIAC FAILURE | Final Rejection | Vanderbilt University |
| 18638894 | USE OF SMALL MOLECULE COMPOUND AND LENALIDOMIDE IN PREPARATION OF DRUG FOR TREATING MULTIPLE MYELOMA | Non-Final OA | Soochow University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy